International Journal of Advanced Networking and Applications

Open Access Open Access  Restricted Access Subscription Access

A Comparative Study on Blockchain Based COVID-19 Vaccine Traceability System


Affiliations
1 Institute of Information and Communication Technology, Bangladesh University of Engineering and Technology, Dhaka-1000, Bangladesh
 

With regards to the COVID-19 pandemic, the fast carry out of an antibody and the execution of an overall vaccination crusade is basic, yet its prosperity will rely upon the accessibility of a functional and straightforward circulation chain that can be evaluated by all applicable partners. In this paper, we examine how blockchain innovation can help in a few parts of COVID-19 inoculation conspire. We present a framework in which blockchain innovation is utilized to surety information honesty and permanence of recipient enlistment for immunization, keeping away from character burglaries and pantomimes. Smart contracts are characterized to screen and track the legitimate antibody dissemination conditions against the protected dealing with rules characterized by antibody makers empowering the familiarity with all organization peers. For immunization organizations, a straightforward and sealed answer for aftereffects self-detailing is given by thinking about the recipient, what's more, administrated antibody affiliation. A model was executed utilizing the Ethereum test organization, Ropsten, considering the COVID-19 immunization dissemination conditions. The outcomes acquired for each on-chain activity can be checked and approved on the Etherscan. Regarding throughput and versatility, the proposed blockchain framework shows promising outcomes while the assessed cost concerning gas for inoculation situation in view of genuine information stays inside sensible cutoff points.

Keywords

Blockchain, Smart Contract, Ethereum COVID-19, Etherscan, Vaccination.
User
Notifications
Font Size

  • A. Rauf, T. Abu-Izneid, A. Olatunde, A. Ahmed Khalil, F. A. Alhumaydhi, T. Tufail, M. A. Shariati, M. Rebezov, Z. M. Almarhoon, Y. N. Mabkhot, A. Alsayari, and K. R. Rengasamy, “Covid-19 pandemic: Epidemiology, Etiology, conventional and non-conventional therapies,” International Journal of Environmental Research and Public Health, vol. 17, no. 21, p. 8155, 2020. W.-K. Chen, Linear Networks and Systems (Book style). Belmont, CA: Wadsworth, 1993, pp. 123–135.

  • K. G. Andersen, A. Rambaut, W. I. Lipkin, E. C. Holmes, and R. F. Garry, “The proximal origin of SARS-COV-2,” Nature Medicine, vol. 26, no. 4, pp. 450–452, 2020.

  • “Who coronavirus (COVID-19) dashboard,” World Health Organization. [Online]. Available: https://covid19.who.int/. [Accessed: 19-Apr-2022].

  • E. Han, M. M. Tan, E. Turk, D. Sridhar, G. M. Leung, K. Shibuya, N. Asgari, J. Oh, A. L. García-Basteiro, J. Hanefeld, A. R. Cook, L. Y. Hsu, Y. Y. Teo, D. Heymann, H. Clark, M. McKee, and H. Legido-Quigley, “Lessons learnt from easing covid-19 restrictions: An analysis of countries and regions in Asia Pacific and Europe,” The Lancet, vol. 396, no. 10261, pp. 1525–1534, 2020.

  • A. Haque and A. B. Pant, “Efforts at COVID-19 Vaccine Development: Challenges and successes,” Vaccines, vol. 8, no. 4, p. 739, 2020.

  • “Race for a COVID-19 vaccine,” EBioMedicine, vol. 55, p. 102817, 2020.

  • U. H. Kartoglu, K. L. Moore, and J. S. Lloyd, “Logistical challenges for potential SARS-COV-2 vaccine and a call to research institutions, developers and manufacturers,” Vaccine, vol. 38, no. 34, pp. 5393–5395, 2020.

  • M. Rahi and A. Sharma, “Mass vaccination against COVID-19 may require replays of the polio vaccination drives,” EClinicalMedicine, vol. 25, p. 100501, 2020.

  • C. Antal, T. Cioara, M. Antal and I. Anghel, "Blockchain Platform For COVID-19 Vaccine Supply Management," in IEEE Open Journal of the Computer Society, vol. 2, pp. 164-178, 2021, doi: 10.1109/OJCS.2021.3067450.

  • V. Chamola, V. Hassija, V. Gupta and M. Guizani, "A Comprehensive Review of the COVID-19 Pandemic and the Role of IoT, Drones, AI, Blockchain, and 5G in Managing its Impact," in IEEE Access, vol. 8, pp. 90225-90265, 2020, doi: 10.1109/ACCESS.2020.2992341.

  • Eisenstadt, M., Ramachandran, M., Chowdhury, N., Third, A., & Domingue, J. (2020). COVID-19 Antibody Test/Vaccination Certification: There's an App for That. IEEE open journal of engineering in medicine and biology, 1, 148–155. https://doi.org/10.1109/OJEMB.2020.2999214

  • H.-I. Shih, C.-J. Wu, Y..-F. Tu, C.-Y. Chi, “Fighting COVID-19: A quick review diagnoses, therapies, vaccines,” Biomed. J., vol. 43, no. 4, 2020, pp. 341–354

  • S. Zafar et al., “COVID-19: Current developments and further opportunities in drug delivery and therapeutics,” Pharmaceutics, vol. 12, pp. 945, 2020.

  • S. Enayati, O. Y. Özaltın, “Optimal influenza vaccine distribution with equity,” Eur. J. Oper. Res., vol. 283, no. 2, pp. 714–725, 2020.

  • Y. Yang, H. Bidkhori, J. Rajgopal, “Optimizing vaccine distribution networks in low and middle-income countries,” Omega, vol. 99, 2021, Art. no. 102197.

  • A. Asgary, M. M. Najafabadi, R. Karsseboom, and J. Wu, “A drivethrough simulation tool for mass vaccination during COVID-19 pandemic,” Healthcare, vol. 8, pp. 469, 2020.

  • D. Marbouhet al. “Blockchain for COVID-19: Review, opportunities, and a trusted tracking system,” Arab J. Sci. Eng., vol. 45, pp. 9895–9911, 2020.

  • R. Lopez, L. Juan, B. Álvarez, and Nicolas, “Blockchain application in the distribution chain of the COVID-19 vaccine: A designing understudy,” Advance. Preprint, Accessed: Dec. 20, 2020. [Online]. Available: https://doi.org/10.31124/advance.12274844.v1.

  • S. McGrail, “IBM launches blockchain-powered digital health pass for COVID-19,” Hit infrastructure, Oct. 2020, Accessed: Dec. 20, 2020. [Online]. Available: https://hitinfrastructure.com/news/ibm-launchesblockchain-powered-digital-health-pass-for-covid-19.

  • N. Korin, “Using blockchain to monitor the COVID19 vaccine supply chain,” Nov 2020, Cologny, Switzerland: World Economic Forum, Pioneers Change Summit, [Online]. Available: https://www.weforum.org/agenda/2020/11/using-blockchain-tomonitor-covid-19-vaccine-supply-chain/

  • A. Chawla, Counterpoint Technology Market Research, Dec. 2020, [Online]. Available: https://www.counterpointresearch.com/blockchain-iot-to-streamline-global-covid-19-vaccine-distribution/

  • N. Alam, M. R. Hasan Tanvir, S. A. Shanto, F. Israt, A. Rahman and S. Momotaj, "Blockchain Based Counterfeit Medicine Authentication System," 2021 IEEE 11th IEEE Symposium on Computer Applications & Industrial Electronics (ISCAIE), 2021, pp. 214-217, doi: 10.1109/ISCAIE51753.2021.9431789.

  • Sylim, P., Liu, F., Marcelo, A., &Fontelo, P. (2018). Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention. JMIR research protocols, 7(9), e10163. https://doi.org/10.2196/10163

  • Uddin, M. (2021). Blockchain Medledger: A Hyperledger Fabric Enabled Drug Traceability System for Counterfeit Drugs in Pharmaceutical Industry. International journal of pharmaceutics, 120235.

  • Uddin, M., Salah, K., Jayaraman, R., Pesic, S., &Ellahham, S. (2021). Blockchain for drug traceability: Architectures and open challenges. Health Informatics Journal. https://doi.org/10.1177/14604582211011228

  • C. Paris, “Supply-chain obstacles led to last month’s cut to Pfizer’s Covid-19 vaccine-rollout target,” Wall Street J., Dec. 3 2020, [Online]. Available: https://www.wsj.com/articles/pfizer-slashed-itscovid-19-vaccine-rollout-target-after-facing-supply-chain-obstacles-11607027787.

  • A. A. Abd-alrazaqet al., “MowafaHouseh, blockchain technologies to mitigate COVID-19 challenges: A scoping review,” Comput. Methods Programs Biomed. Update, 2020, Art. no. 100001.

  • -Bagozzi D, Lindmeier C. World Health Organization. 2018 Nov 28. 1 in 10 medical products in developing countries is substandard or falsified: WHO urges governments to take action URL:http://www.who.int/en/news-room/detail/28-11-2017-1-in-10-medical-products-in-developing-countries-is-substandard-or-falsified [accessed 2018-01-19]

  • World Health Organization. 2005 May 5. Counterfeit medicines: some frequently asked questions -May 2005 URL:http://www.wpro.who.int/mediacentre/factsheets/fs_20050 506/en [accessed 2018-01-19]

  • The Philippine Star. Philstar. 2017 Dec 4. Editorial - Fake drugs URL:http://www.philstar.com/opinion/2017/12/05/1765363/ editorial-fake-drugs [accessed 2018-01-19]

  • World Health Organization. In: Jean-claude F, editor. A study on the public health and socioeconomic impact of substandard and falsified medical products. Geneva: World Health Organization; Nov 2017:77.

  • Interpol. Interpol.int. 2018. The dangers of counterfeit medical products URL:https://www.interpol.int/Crime-areas/Pharmaceutical-crime/The-dangers [accessed 2018-01-19]

  • Learningenglish.voanews. 2010 Feb 22. The dangers of counterfeit drugs (first of two parts) URL:https://learningenglish.voanews.com/a/a-23-2010-02-22-voa1-84962182/130711.html [accessed 2018-01-19]

  • Clark J. Huffingtonpost. 2012 Apr 23. Gambling with your health: the dangers of counterfeit drugs URL:https://www.huffingtonpost.com/john-clark/counterfeit-drugs-pfizer_b_1435111.html [accessed 2018-01-19]

  • Bichell RE. NPR. 2017 Nov 29. Fake drugs are a major global problem, WHO reports URL:https://www.npr.org/sections/goatsandsoda/2017/11/29/567229552/bad-drugs-are-a-major-global-problem-who-reports [accessed 2018-01-19]

  • Blackstone EA, Fuhr JP, Pociask S. The health and economic effects of counterfeit drugs. Am Health Drug Benefits 2014 Jun 1;7(4):216-224

  • Sugita M, Miyakawa M. Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example. Environ Health Prev Med 2010 Jul;15(4):244-25 [doi: 10.1007/s12199-010-0134-5]

  • Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med 2005 Apr;2(4):e100 [doi: 10.1371/journal.pmed.0020100]

  • Gautam CS, Utreja A, Singal GL. Spurious and counterfeit drugs: a growing industry in the developing world. Postgrad Med J 2009 May;85(1003):251-256. [doi: 10.1136/pgmj.2008.073213]

  • Johnston A, Holt DW. Substandard drugs: a potential crisis for public health. Br J Clin Pharmacol 2014 Aug;78(2):218-243 [doi: 10.1111/bcp.12298]

  • Kelesidis T, Falagas ME. Substandard/counterfeit antimicrobial drugs. Clin Microbiol Rev 2015 Apr;28(2):443-464 [doi: 10.1128/CMR.00072-14]

  • Food and Drug Administration Philippines. FDA. 2017. FDA warns vs fake products URL:http://www.fda.gov.ph/announcement/474982-fda-warns-vs-fake-products [accessed 2018-01-19]

  • Babar Z. Pharmaceutical Policy in Countries with Developing Healthcare Systems. Cham, Switzerland: Springer International Publishing; 2017.

  • Ichikawa DE, Kashiyama M, Ueno T. Tamper-resistant mobile health using blockchain technology. JMIR MhealthUhealth 2017 Jul 26;5(7):e111 [doi: 10.2196/mhealth.7938]

  • Mackey TK, Nayyar G. A review of existing and emerging digital technologies to combat the global trade in fake medicines. Expert Opin Drug Saf 2017 May;16(5):587-602. [doi: 10.1080/14740338.2017.1313227]

  • Chapron G. The environment needs cryptogovernance. Nature 2017 May 22;545(7655):403-405. [doi: 10.1038/545403a]

  • C. Pop, T. Cioara, I. Anghel, M. Antal, and I. Salomie, “Distributed ledger technology review and decentralized applications development guidelines,” Future Internet, vol. 13, pp. 62, 2021. [Online]. Available: https://doi.org/10.3390/fi13030062

  • C. Pop, T. Cioara, M. Antal, I. Anghel, I. Salomie, and M. Bertoncini, “Blockchain based decentralized management of demand response programs in smart energy grids,” Sensors, vol. 18, no. 1, pp. 162, 2018.

  • Y. Wu et al., “A Bitcoin transaction network analytic method for future blockchain forensic investigation,” IEEE Trans. Netw. Sci. Eng., to be published, doi: 10.1109/TNSE.2020.2970113.

  • J. Chen, X. Xia, D. Lo, J. Grundy, X. Luo, and T. Chen, “Defining smart contract defects on ethereum,” IEEE Trans. Softw. Eng., to be published, doi: 10.1109/TSE.2020.2989002

  • Jain, A., &Soni, B. K. (2017). Secure Modern Healthcare System Based on Internet of Things and Secret Sharing of IoT Healthcare Data. International Journal of Advanced Networking andApplications, 8(6), 3283.

  • Ramya, M., Kowsalya, K., & Ramesh, V. (2016). Mitigating Link Failures & Implementing Security Mechanism in Multipath Flows for Data Plane Resources. International Journal of Advanced Networking and Applications, 7(5), 2876.


Abstract Views: 233

PDF Views: 0




  • A Comparative Study on Blockchain Based COVID-19 Vaccine Traceability System

Abstract Views: 233  |  PDF Views: 0

Authors

Sadah Anjum Shanto
Institute of Information and Communication Technology, Bangladesh University of Engineering and Technology, Dhaka-1000, Bangladesh

Abstract


With regards to the COVID-19 pandemic, the fast carry out of an antibody and the execution of an overall vaccination crusade is basic, yet its prosperity will rely upon the accessibility of a functional and straightforward circulation chain that can be evaluated by all applicable partners. In this paper, we examine how blockchain innovation can help in a few parts of COVID-19 inoculation conspire. We present a framework in which blockchain innovation is utilized to surety information honesty and permanence of recipient enlistment for immunization, keeping away from character burglaries and pantomimes. Smart contracts are characterized to screen and track the legitimate antibody dissemination conditions against the protected dealing with rules characterized by antibody makers empowering the familiarity with all organization peers. For immunization organizations, a straightforward and sealed answer for aftereffects self-detailing is given by thinking about the recipient, what's more, administrated antibody affiliation. A model was executed utilizing the Ethereum test organization, Ropsten, considering the COVID-19 immunization dissemination conditions. The outcomes acquired for each on-chain activity can be checked and approved on the Etherscan. Regarding throughput and versatility, the proposed blockchain framework shows promising outcomes while the assessed cost concerning gas for inoculation situation in view of genuine information stays inside sensible cutoff points.

Keywords


Blockchain, Smart Contract, Ethereum COVID-19, Etherscan, Vaccination.

References